Related Experiment Videos
Binding effects of concanavalin A on a coronavirus
Summary
Concanavalin A, a plant lectin, binds to coronavirus envelopes, disrupting hemagglutination and transiently affecting infectivity. This binding is specific to the viral envelope, not stripped virions.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Hemagglutinating encephalomyelitis virus (HEV) is a type of Coronavirus.
- Concanavalin A (ConA) is a plant lectin known to bind to carbohydrate moieties.
Purpose of the Study:
- To investigate the interaction between Concanavalin A and HEV.
- To determine the effect of ConA binding on viral properties such as hemagglutination and infectivity.
Main Methods:
- Treatment of HEV suspensions with Concanavalin A.
- Assay of hemagglutination properties.
- Assessment of viral infectivity.
- Electron microscopy to visualize ConA binding and viral aggregation.
Main Results:
- Concanavalin A binds to the envelope of HEV.
- ConA treatment results in loss of hemagglutination properties.
- Viral infectivity is transiently interfered with after ConA treatment.
- Electron microscopy reveals granular deposits of ConA on the viral envelope and virus aggregation.
- ConA does not bind to HEV virions lacking their envelopes.
Conclusions:
- Concanavalin A specifically interacts with the HEV viral envelope.
- This interaction alters key viral functions, including hemagglutination and infectivity.
- The viral envelope is crucial for ConA binding.